First Time Loading...

Dialogue Health Technologies Inc
TSX:CARE

Watchlist Manager
Dialogue Health Technologies Inc Logo
Dialogue Health Technologies Inc
TSX:CARE
Watchlist
Price: 5.14 CAD 0.1% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Dialogue Health Technologies, Inc. engages in the development of telemedicine platform. [ Read More ]

The intrinsic value of one CARE stock under the Base Case scenario is 4.76 CAD. Compared to the current market price of 5.14 CAD, Dialogue Health Technologies Inc is Overvalued by 7%.

Key Points:
CARE Intrinsic Value
Base Case
4.76 CAD
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dialogue Health Technologies Inc

Backtest CARE Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CARE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Dialogue Health Technologies Inc's business.

What risks and challenges
does Dialogue Health Technologies Inc face in the near future?

Summarize the latest earnings report
of Dialogue Health Technologies Inc.

Provide P/E
for Dialogue Health Technologies Inc and its competitors.

Financials

Balance Sheet Decomposition
Dialogue Health Technologies Inc

Current Assets 77.4m
Cash & Short-Term Investments 54.2m
Receivables 19.6m
Other Current Assets 3.6m
Non-Current Assets 34.3m
PP&E 1.4m
Intangibles 30.3m
Other Non-Current Assets 2.6m
Current Liabilities 19.9m
Accounts Payable 16.9m
Other Current Liabilities 2.9m
Non-Current Liabilities 1m
Long-Term Debt 583k
Other Non-Current Liabilities 422k
Efficiency

Earnings Waterfall
Dialogue Health Technologies Inc

Revenue
93.5m CAD
Cost of Revenue
-41m CAD
Gross Profit
52.5m CAD
Operating Expenses
-67m CAD
Operating Income
-14.6m CAD
Other Expenses
-4.3m CAD
Net Income
-18.9m CAD

Free Cash Flow Analysis
Dialogue Health Technologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CARE Profitability Score
Profitability Due Diligence

Dialogue Health Technologies Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Exceptional Revenue Growth Forecast
Positive 1-Year Revenue Growth
24/100
Profitability
Score

Dialogue Health Technologies Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

CARE Solvency Score
Solvency Due Diligence

Dialogue Health Technologies Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
62/100
Solvency
Score

Dialogue Health Technologies Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARE Price Targets Summary
Dialogue Health Technologies Inc

Wall Street analysts forecast CARE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARE is 4.93 CAD .

Lowest
Price Target
Not Available
Average
Price Target
4.93 CAD
4% Downside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CARE Price
Dialogue Health Technologies Inc

1M 1M
-
6M 6M
+0%
1Y 1Y
+35%
3Y 3Y
-64%
5Y 5Y
-64%
10Y 10Y
-64%
Annual Price Range
5.14
52w Low
2.92
52w High
5.14
Price Metrics
Average Annual Return -49.23%
Standard Deviation of Annual Returns
N/A
Max Drawdown -89%
Shares Statistics
Market Capitalization 345.4m CAD
Shares Outstanding 67 445 200
Percentage of Shares Shorted 0.18%

CARE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Dialogue Health Technologies Inc Logo
Dialogue Health Technologies Inc

Country

Canada

Industry

Health Care

Market Cap

345.4m CAD

Dividend Yield

0%

Description

Dialogue Health Technologies, Inc. engages in the development of telemedicine platform. The company is headquartered in Montreal, Quebec and currently employs 270 full-time employees. The company went IPO on 2021-03-30. The Company’s integrated proprietary product, technology and service providing on-demand access to care. The Company’s Integrated Health Platform is a one-stop healthcare hub that centralizes all its programs in a single application by providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet. Through the Company’s vertically integrated platform, its members and their dependents have access to a team of multidisciplinary professionals who provide wellness services. The firm also offers its members and their dependents access to an employee assistance program (EAP) as well as an Internet-based cognitive behavioral therapy (iCBT) program and an occupational health and safety (OHS) program for customers in Germany.

Contact

QUEBEC
MONTREAL
390 Notre-Dame W, Suite 200
https://dialogue.co/

IPO

2021-03-30

Employees

270

Officers

Co-Founder, CEO & Director
Mr. Cherif Habib
Co-Founder & CTO
Mr. Alexis Smirnov
Chief Financial Officer
Mr. Navaid Mansuri
Chief Operating Officer
Mr. Jean-Nicolas Guillemette
Director of Investor Relations
Mr. Jean-Marc Ayas
Gen. Counsel, Corp. Sec. & Chief Privacy Officer
Ms. Nathalie Delisle
Show More
Director of Public & Gov. Relations
Jean-Christophe de Le Rue
VP of Marketing
Lilian Lau
VP of Sales
Randy Wetmore
Sr. Vice-Pres of Commercial
Jennifer Buckley
Show Less

See Also

Discover More
What is the Intrinsic Value of one CARE stock?

The intrinsic value of one CARE stock under the Base Case scenario is 4.76 CAD.

Is CARE stock undervalued or overvalued?

Compared to the current market price of 5.14 CAD, Dialogue Health Technologies Inc is Overvalued by 7%.